These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
378 related items for PubMed ID: 32560557
1. Expression Changes and Impact of the Extracellular Matrix on Etoposide Resistant Human Retinoblastoma Cell Lines. Reinhard J, Wagner N, Krämer MM, Jarocki M, Joachim SC, Dick HB, Faissner A, Kakkassery V. Int J Mol Sci; 2020 Jun 17; 21(12):. PubMed ID: 32560557 [Abstract] [Full Text] [Related]
2. Protein Profiling of WERI-RB1 and Etoposide-Resistant WERI-ETOR Reveals New Insights into Topoisomerase Inhibitor Resistance in Retinoblastoma. Kakkassery V, Gemoll T, Kraemer MM, Sauer T, Tura A, Ranjbar M, Grisanti S, Joachim SC, Mergler S, Reinhard J. Int J Mol Sci; 2022 Apr 06; 23(7):. PubMed ID: 35409416 [Abstract] [Full Text] [Related]
6. Characterization of etoposide- and cisplatin-chemoresistant retinoblastoma cell lines. Busch M, Papior D, Stephan H, Dünker N. Oncol Rep; 2018 Jan 06; 39(1):160-172. PubMed ID: 29192327 [Abstract] [Full Text] [Related]
7. Altered calcium regulation by thermosensitive transient receptor potential channels in etoposide-resistant WERI-Rb1 retinoblastoma cells. Mergler S, Cheng Y, Skosyrski S, Garreis F, Pietrzak P, Kociok N, Dwarakanath A, Reinach PS, Kakkassery V. Exp Eye Res; 2012 Jan 06; 94(1):157-73. PubMed ID: 22182671 [Abstract] [Full Text] [Related]
8. Role of Protein Tyrosine Phosphatase Receptor Type E (PTPRE) in Chemoresistant Retinoblastoma. Mohren L, Doege A, Miroschnikov N, Dräger O, Busch MA, Dünker N. Int J Mol Sci; 2024 Apr 22; 25(8):. PubMed ID: 38674157 [Abstract] [Full Text] [Related]
9. Different transcriptome profiles between human retinoblastoma Y79 cells and an etoposide-resistant subline reveal a chemoresistance mechanism. Song WP, Zheng S, Yao HJ, Zhou XF, Li R, Zhang CY, Zhao JY, Wang LW, Shao RG, Li L. BMC Ophthalmol; 2020 Mar 06; 20(1):92. PubMed ID: 32143590 [Abstract] [Full Text] [Related]
10. Ascorbate-induced oxidative stress mediates TRP channel activation and cytotoxicity in human etoposide-sensitive and -resistant retinoblastoma cells. Oronowicz J, Reinhard J, Reinach PS, Ludwiczak S, Luo H, Omar Ba Salem MH, Kraemer MM, Biebermann H, Kakkassery V, Mergler S. Lab Invest; 2021 Jan 06; 101(1):70-88. PubMed ID: 32948812 [Abstract] [Full Text] [Related]
11. Impact of RARα and miR-138 on retinoblastoma etoposide resistance. Busch M, Miroschnikov N, Dankert JT, Wiesehöfer M, Metz K, Stephan H, Dünker N. Tumour Biol; 2021 Jan 06; 43(1):11-26. PubMed ID: 33935126 [Abstract] [Full Text] [Related]
12. Molecular deregulation induced by silencing of the high mobility group protein A2 gene in retinoblastoma cells. Venkatesan N, Krishnakumar S, Deepa PR, Deepa M, Khetan V, Reddy MA. Mol Vis; 2012 Jan 06; 18():2420-37. PubMed ID: 23077401 [Abstract] [Full Text] [Related]
13. Overexpression of Biglycan is Associated with Resistance to Rapamycin in Human WERI-Rb-1 Retinoblastoma Cells by Inducing the Activation of the Phosphatidylinositol 3-Kinases (PI3K)/Akt/Nuclear Factor kappa B (NF-κB) Signaling Pathway. Fang D, Lai Z, Wang Y. Med Sci Monit; 2019 Sep 04; 25():6639-6648. PubMed ID: 31483776 [Abstract] [Full Text] [Related]
14. Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells. Dalgard CL, Gonzalez M, deNiro JE, O'Brien JM. Invest Ophthalmol Vis Sci; 2009 Oct 04; 50(10):4542-51. PubMed ID: 19443717 [Abstract] [Full Text] [Related]
15. Inhibition of MMP-2 and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma. Webb AH, Gao BT, Goldsmith ZK, Irvine AS, Saleh N, Lee RP, Lendermon JB, Bheemreddy R, Zhang Q, Brennan RC, Johnson D, Steinle JJ, Wilson MW, Morales-Tirado VM. BMC Cancer; 2017 Jun 20; 17(1):434. PubMed ID: 28633655 [Abstract] [Full Text] [Related]
16. Basic fibroblast growth factor impact on retinoblastoma progression and survival. Cebulla CM, Jockovich ME, Piña Y, Boutrid H, Alegret A, Kulak A, Hackam AS, Bhattacharya SK, Feuer WJ, Murray TG. Invest Ophthalmol Vis Sci; 2008 Dec 20; 49(12):5215-21. PubMed ID: 18614803 [Abstract] [Full Text] [Related]
17. The decreased adhesion of Y79 retinoblastoma cells to extracellular matrix proteins is due to a deficit of integrin receptors. Skubitz AP, Grossman MD, McCarthy JB, Wayner EA, Cameron JD. Invest Ophthalmol Vis Sci; 1994 May 20; 35(6):2820-33. PubMed ID: 8188477 [Abstract] [Full Text] [Related]
18. Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover. Phillips PA, McCarroll JA, Park S, Wu MJ, Pirola R, Korsten M, Wilson JS, Apte MV. Gut; 2003 Feb 20; 52(2):275-82. PubMed ID: 12524413 [Abstract] [Full Text] [Related]
19. IFN-gamma inducibility of class II transactivator is specifically lacking in human tumour lines: relevance to retinoblastoma protein rescue of IFN-gamma inducibility of the HLA class II genes. Lu Y, Tschickardt ME, Schmidt BJ, Blanck G. Immunol Cell Biol; 1997 Aug 20; 75(4):325-32. PubMed ID: 9315472 [Abstract] [Full Text] [Related]
20. Upregulation of sodium iodide symporter (NIS) protein expression by an innate immunity component: Promising potential for targeting radiosensitive retinoblastoma. Samuel J, Singh N, Kanwar JR, Krishnakumar S, Kanwar RK. Exp Eye Res; 2015 Oct 20; 139():108-14. PubMed ID: 26213306 [Abstract] [Full Text] [Related] Page: [Next] [New Search]